Frankfurt, Germany

Mirko Hechenberger

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Merz Pharma Gmbh & Co Kgaa. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mirko Hechenberger. Retrieved from https://idiyas.com/inventor/mirko-hechenberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mirko Hechenberger: Innovator in Pharmaceutical Chemistry

Introduction

Mirko Hechenberger is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptors in the brain.

Latest Patents

Hechenberger holds 2 patents, with his latest inventions focusing on substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators. These patents detail the structure and application of pyrazolopyrimidine derivatives, which have potential therapeutic uses in treating various neurological conditions.

Career Highlights

Hechenberger is currently employed at Merz Pharma GmbH & Co. KGaA, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new treatments that can improve patient outcomes.

Collaborations

Throughout his career, Hechenberger has collaborated with esteemed colleagues such as Wojciech Danysz and Andrzej Dekundy. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mirko Hechenberger's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the field. His ongoing work at Merz Pharma continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…